Human Immunodeficiency Virus and Acquired ImmuneDeficiency Syndrome: What is the Least a General Medicine TraineeShould Know
Abstract
Human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) have been a global health issue in developed countries. It has significant complications that lead to its morbidities and mortality. It has a substantial impact on the quality of life and the health economy. In addition, there is no cure, which makes it a lifelong disease. However, with the advances in healthcare and new medications, the disease can be controlled. HIV is on the rise in Pakistan and isn't a rare disease anymore. There are many factors which can be reasons for this endemic disease, including globalisation and travelling. However, many local factors also contribute to its spread, such as blood transfusions, needle sharing, and IVDU, razors and needle sharing by barbers and quacks respectively, & changing sexual preferences and practices. Therefore, our trainees should know the main points of the disease. The review has avoided going into the molecular or microbiological details of the virus or the disease, as that can distract them from knowing the bare minimum clinically essential information, and it is also beyond the scope of those who are not in ID or Microbiology training.
How to Cite This Article
Hussain A, Avais J. Human Immunodeficiency Virus and Acquired ImmuneDeficiency Syndrome: What is the Least a General Medicine TraineeShould Know. J Pak Soc Intern Med. 2025;6(3):215–222. doi:10.70302/jpsim.v6i3.2540
Conflict of Interest
All authors declare no competing interests.
Funding
No specific funding was received for this research.
Funder information follows the Crossref Funder Registry standard.
References
- Meissner ME, Talledge N, Mansky LM. Molecular Biology and Diversification of Human Retroviruses. Front Virol. 2022;2.
- Coffin, J. M. Molecular biology of HIV. In The Evolution of HIV, ed. K. A. Crandall, 1999;3-40.
- Friedland, G. and Klein R. Transmission of HIV. Nejm 1987;317(18):1125-35.
- Downs AM, Vincenzi De I. Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. Europeon study Group in heterosexual transmission of HIV. J Acquir Immune Defic Syndr Hum Retroviral. 1996; 11(4): 388- 95.
- Burudpakdee C, Near AM, Tse J, Faccone J, Rodriguez PL, Karichu JK. Real-world HIV diagnostic testing patterns in the United States. Am J Manag Care. 2022;28(2):e42-e48
- Xu Y, Ollerton MT, Connick E. Follicular T-cell subsets in HIV infection: recent advances in pathogenesis research. Curr Opin HIV AIDS. 2019;14(2):71-76.
- Damtie D, Yismaw G, Woldeyohannes D, Anagaw B. Common opportunistic infections and their CD4 cell correlates among HIV-infected patients attending at antiretroviral therapy clinic of Gondar University Hospital, Northwest Ethiopia. BMC Res Notes. 2013;6(2):534.
- Knight CL. Physical Examination in Human Immunodeficiency Virus Disease. Med Clin North Am. 2022;106(3):527-536.
- Saag MS. HIV Infection - Screening, Diagnosis, and Treatment. N Engl J Med. 2021;384(22):2131-43.
- Amborzia, J. and Levy J. A. Epidemiology, natural history and Pathogenesis of HIV Infection. In Sexually Transmitted Diseases, 3rd ed. KK Holmes, PF Sparling, P.A. Mardh, SM Lemon, W.E. Stamm, P. Piot, and J.N. Wasserheit, 1998; 251–58.
- Lapins J, Gaines H, Lindbäck S, Lidbrink P, Emtestam L. Skin and mucosal characteristics of symptomatic primary HIV-1 infection. AIDS Patient Care STDS. 1997;11(2):67-70.
- Palella Jr FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection; N Eng J Med. 1998; 338(13): 853-60.
- Pope, M. and Haase, A. Transmission; acute HIV-1 infection and the quest for strategies to prevent infection. Nat Med. 2003; 9(7): 847-52.
- Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, et al. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 2015;373(9):795-807.
- DeKoven S, Naccarato M, Brumme CJ, Tan DHS. Treatment-emergent reverse transcriptase resistance during antiretroviral therapy with bictegravir, tenofovir alafenamide, and emtricitabine: A case series. HIV Med. 2023;24(11):1137-43.
- Gandhi RT, Bedimo R, Hoy JF, Landovitz RJ, Smith DM, Eaton EF, Lehmann C, et al. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 R ecommendations of the International Antiviral Society-USA Panel. JAMA. 2023;329(1):63-84.
- Wensing AM, Calvez V, Ceccherini-Silberstein F, Charpentier C, Günthard HF, Paredes R, et al. 2022 update of the drug resistance mutations in HIV-1. Top Antivir Med. 2022;30(4):559-574
- Yin Z, Rice BD, Waight P, Miller E, George R, Brown AE, et al. Invasive pneumococcal disease among HIV-positive individuals, 2000-2009. AIDS. 2012;26(1):87-94
- Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. 2nd ed. World Health Organization; Geneva: 2016.
- Blair HA. Ibalizumab: A Review in Multidrug-Resistant HIV-1 Infection. Drugs. 2020;80(2):189-196.
- Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach: 2010 Revision. World Health Organization; Geneva: 2010.
- Thompson MA, Horberg MA, Agwu AL, Colasanti JA, Jain MK, Short WR, et al. Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2021;73(11):e3572-605.
- Tripathi, K.D. Essentials of Medical Pharmacology, 6th edition, Jaypee brothers, medical publishers Ltd., New Delhi; 798-810.
- Edwards JK, Cole SR, Breger TL. Mortality among persons entering HIV care compared with the general US population: an observational study. Ann Intern Med. 2021;174(9):1197-206.
Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.